As major U.S. indexes like the Dow Jones, S&P 500, and Nasdaq Composite are on track for gains amid positive earnings reports and stable inflation data, investors continue to navigate a landscape shaped by economic resilience and evolving corporate performances. In this context, growth stocks with significant insider ownership can be particularly appealing as they often indicate strong internal confidence in the company's future potential and alignment of interests with shareholders.
Name | Insider Ownership | Earnings Growth |
Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 25.2% |
Super Micro Computer (NasdaqGS:SMCI) | 14.4% | 24.3% |
On Holding (NYSE:ONON) | 19.1% | 29.7% |
Kingstone Companies (NasdaqCM:KINS) | 20.8% | 24.9% |
Clene (NasdaqCM:CLNN) | 21.6% | 59.1% |
BBB Foods (NYSE:TBBB) | 22.9% | 40.4% |
Credit Acceptance (NasdaqGS:CACC) | 14.1% | 48% |
Capital Bancorp (NasdaqGS:CBNK) | 31.1% | 28.1% |
MoneyLion (NYSE:ML) | 20.3% | 92.4% |
Credo Technology Group Holding (NasdaqGS:CRDO) | 13% | 66.2% |
Click here to see the full list of 204 stocks from our Fast Growing US Companies With High Insider Ownership screener.
Let's uncover some gems from our specialized screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for severe allergic reactions with a market cap of approximately $1.39 billion.
Operations: The company generates revenue primarily from its pharmaceuticals segment, amounting to $2.57 million.
Insider Ownership: 19.1%
Earnings Growth Forecast: 58.7% p.a.
ARS Pharmaceuticals is positioned as a growth company with high insider ownership, driven by its innovative product neffy, an FDA-approved epinephrine nasal spray. Despite recent insider selling, the company's revenue is forecast to grow significantly faster than the market at 45.5% annually. Recent licensing agreements and approvals in multiple regions, including Europe and Canada, provide substantial revenue potential through upfront payments and milestone-based earnings. However, current revenues remain modest at US$3 million amidst ongoing losses.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Cadre Holdings, Inc. manufactures and distributes safety equipment for protection in hazardous situations both in the United States and internationally, with a market cap of approximately $1.57 billion.
Operations: The company's revenue segments consist of $449.48 million from Product and $99.39 million from Distribution.
Insider Ownership: 33.8%
Earnings Growth Forecast: 30.1% p.a.
Cadre Holdings is experiencing significant growth, with earnings projected to increase by 30.1% annually, outpacing the broader US market. Despite a recent decline in quarterly sales and net income, the company maintains a robust financial position with US$458 million available for growth initiatives. Insider activity shows more buying than selling recently, reflecting confidence in future prospects. The company is actively seeking acquisitions to scale its nuclear products category further.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Carriage Services, Inc. operates in the United States offering funeral and cemetery services and merchandise, with a market cap of $635.26 million.
Operations: The company generates revenue through its funeral segment, which accounts for $266.69 million, and its cemetery segment, contributing $138.64 million.
Insider Ownership: 10.8%
Earnings Growth Forecast: 23.8% p.a.
Carriage Services is poised for growth, with earnings expected to rise 23.8% annually, surpassing the US market's average. Despite revenue growth lagging behind market expectations at 4.6%, the company trades at a substantial discount to its estimated fair value and offers good relative value compared to peers. Recent insider activity shows more buying than selling, indicating confidence in future performance. The appointment of John Enwright as CFO underscores a focus on strategic financial leadership and transformative growth objectives.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include NasdaqGM:SPRY NYSE:CDRE and NYSE:CSV.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。